Abel Ang

Mr. Abel Ang has been the Group CEO of Advanced MedTech Group since 2014. Advanced MedTech is a US$225M high-growth medical device company focused on expanding its substantial operating businesses in urology, and nurturing disruptive medtech innovations. Advanced MedTech is owned by Temasek Holdings, a US$240B global fund. Mr. Ang was formerly Senior Advisor to the CEO of Integer (NYSE: ITGR), the largest contract manufacturer of medical implants in the world. Prior to Integer, Mr. Ang held several executive roles at Hill-Rom, Inc (NYSE:HRC) including President, Asia Pacific, Chief Technology Officer, and Vice-President and General Manager of Hill-Rom’s US$420M Global Surfaces and Therapy Business Unit; and Vice-President for International Business and Technology Development.

Mr. Ang sits on several Boards of innovative technology companies, including that of Accelerate Technologies which provides access to on of the world’s largest pool of intellectual property and knowledge generated by over 5,000 researchers and staff at A*STAR’s research institutes.

Mr. Ang is also an Adjunct Associate Professor at the Nanyang Business School in Singapore and Waseda University in Japan, where he teaches in their respective MBA programs.